Head & Neck Cell Line: FaDu

Athymic Nude Mouse

• Internal Xenograft Data
• Activity of the Vascular-Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid against Human Head and Neck Carcinoma Xenografts
• Genetically Targeted Radiotherapy of Head and Neck Squamous Cell Carcinoma Using the Sodium-Iodide Symporter (NIS)
• Assessment of Epidermal Growth Factor Receptor (EGFR) Signaling in Paired Colorectal Cancer and Normal Colon Tissue Samples Using Computer-Aided Immunohistochemical Analysis
• Acute Vascular Disruption Induced by Asa404 in an Orthotopic Model of Human Head and Neck Cancer

NU/NU Nude Mouse

• Promoter Methylation in Head and Neck Squamous Cell Carcinoma Cell Lines Is Significantly Different than Methylation in Primary Tumors and Xenografts<

Fox Chase SCID Mouse (C.B.17 SCID)

• Benzethonium Chloride: A Novel Anticancer Agent Identified
• Identification of a Novel Topoisomerase Inhibitor Effective in Cells Overexpressing Drug Efflux Transporters

CD-1 Nude Mouse

• Effects of Palifermin on Antitumor Activity of Chemotherapeutic and Biological Agents in Human Head and Neck and Colorectal Carcinoma Xenograft Models
• Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell

BALB/c Nude Mouse

• Glucose-regulated protein 78 regulates multiple malignant phenotypes in head and neck cancer and may serve as a molecular target of therapeutic Intervention
• VEGF₁₆₅ antisense RNA suppresses oncogenic properties of human esophageal squamous cell carcinoma
• Microenvironmental Parameters in Head and Neck Tumors

NOD SCID Mouse

• Cisplatin Treatment Induces a Transient Increase in Tumorigenic Potential Associated with High Interleukin-6Expression in Head and Neck Squamous Cell Carcinoma